Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

2.5K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.5K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

6.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

2.9K
Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
2.9K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

5.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.0K
ATP Driven Pumps II: P-type Pumps01:34

ATP Driven Pumps II: P-type Pumps

5.1K
The P-type pumps are a large family of integral membrane transporter ATPases. They are divided into five major types based on substrate specificity, from I to V.
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
5.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

15.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Pathophysiological Interrelationship Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease.

Antioxidants (Basel, Switzerland)·2026
Same author

New cell lines derived from larvae of the neotropical fruit fly <i>Drosophila willistoni</i> persistently infected with <i>Wolbachia</i>.

Fly·2026
Same author

miR-181a post-transcriptionally targets GRK2 to limit maladaptive signaling in cardiomyocytes.

Frontiers in cardiovascular medicine·2026
Same author

Single Centre Experience With the Balloon-Expandable Myval Transcatheter Aortic Valve System in Patients With Bicuspid Anatomy: 1 Year Follow-Up.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Cys340Ser Mutation Abolishing S-Nitrosylation Drives GRK2 Mitochondrial Localization and Dysfunction.

Cells·2026
Same author

GATA4-targeted compounds induce apoptosis and diminish viability of hepatoblastoma cells.

PloS one·2026

Related Experiment Video

Updated: May 4, 2026

Monitoring ER/SR Calcium Release with the Targeted Ca2+ Sensor CatchER+
12:30

Monitoring ER/SR Calcium Release with the Targeted Ca2+ Sensor CatchER+

Published on: May 19, 2017

14.2K

p38α regulates SERCA2a function.

Leena Kaikkonen1, Johanna Magga1, Veli-Pekka Ronkainen2

  • 1Dept. of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, P.O. BOX 5000, FI-90014 Oulu, Finland.

Journal of Molecular and Cellular Cardiology
|December 24, 2013
PubMed
Summary

Inhibiting p38α in the heart enhances phospholamban (PLB) phosphorylation, improving calcium handling and cardiac contractility. This study reveals a new mechanism for regulating heart function through p38 pathway modulation.

Keywords:
AMVMARVMCardiac contractilityET-1G protein coupled receptor kinaseGRKI-1MAPKNRVMOAPLBPP1PP2APhospholambanSERCA2aadult mouse ventricular myocyteadult rat ventricular myocytedndominant negativeendothelin-1inhibitor-1mitogen-activated protein kinaseneonatal rat ventricular myocyteokadaic acidp38phospholambanprotein phosphatase-1protein phosphatase-2Asarco/endoplasmic reticulum Ca(2+) ATPase

More Related Videos

Live Cell Calcium Imaging Combined with siRNA Mediated Gene Silencing Identifies Ca2+ Leak Channels in the ER Membrane and their Regulatory Mechanisms
13:40

Live Cell Calcium Imaging Combined with siRNA Mediated Gene Silencing Identifies Ca2+ Leak Channels in the ER Membrane and their Regulatory Mechanisms

Published on: July 7, 2011

20.0K
Purification of the Sarco-Endoplasmic Reticulum Ca2+-ATPase from Rabbit Muscle
08:37

Purification of the Sarco-Endoplasmic Reticulum Ca2+-ATPase from Rabbit Muscle

Published on: March 21, 2025

891

Related Experiment Videos

Last Updated: May 4, 2026

Monitoring ER/SR Calcium Release with the Targeted Ca2+ Sensor CatchER+
12:30

Monitoring ER/SR Calcium Release with the Targeted Ca2+ Sensor CatchER+

Published on: May 19, 2017

14.2K
Live Cell Calcium Imaging Combined with siRNA Mediated Gene Silencing Identifies Ca2+ Leak Channels in the ER Membrane and their Regulatory Mechanisms
13:40

Live Cell Calcium Imaging Combined with siRNA Mediated Gene Silencing Identifies Ca2+ Leak Channels in the ER Membrane and their Regulatory Mechanisms

Published on: July 7, 2011

20.0K
Purification of the Sarco-Endoplasmic Reticulum Ca2+-ATPase from Rabbit Muscle
08:37

Purification of the Sarco-Endoplasmic Reticulum Ca2+-ATPase from Rabbit Muscle

Published on: March 21, 2025

891

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Cell Signaling

Background:

  • Cardiac contractility is modulated by cAMP-dependent protein kinase (PKA) and p38 mitogen-activated protein kinase (MAPK).
  • p38 MAPK acts as a negative regulator of cardiac contractile function.
  • Understanding p38's role is crucial for identifying therapeutic targets.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying the positive inotropic effect of p38 inhibition.
  • To investigate how p38 signaling influences cardiac contractility.

Main Methods:

  • Utilized isolated adult and neonatal cardiomyocytes and perfused rat hearts.
  • Employed chemical p38 inhibition, dominant-negative p38α, and p38α RNA interference (RNAi).
  • Assessed phospholamban (PLB) phosphorylation, Ca(2+)-transient decay, and sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA) function.

Main Results:

  • p38 inhibition, specifically p38α, enhanced PLB phosphorylation.
  • Reduced Ca(2+)-transient decay time indicated improved SERCA function and increased cardiomyocyte contractility.
  • p38 inhibition decreased protein phosphatase 2A (PP2A) activity, leading to protein phosphatase inhibitor-1 (I-1) phosphorylation and PP1 inhibition.

Conclusions:

  • Inhibition of p38α promotes PLB phosphorylation and enhances diastolic Ca(2+) uptake.
  • This study identifies a novel mechanism regulating cardiac contractility via p38 pathway modulation.
  • Findings suggest p38α as a potential therapeutic target for enhancing cardiac function.